Metadeq

Curated by Signal

Developer of a blood-based diagnostic test for the detection of NASH and metabolic diseases

Overview

Developer of a blood-based diagnostic test for the detection of NASH and metabolic diseases. The company uses AI technology to develop next-generation liquid biopsy solutions for the detection of Non-alcoholic fatty liver disease, Non-alcoholic steatohepatitis, and liver fibrosis.

Key facts

Founded: 2019
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Yourgene Health
Provider of non-invasive prenatal genetic tests and genomic services
Life Sciences TechnologyManchester, United Kingdom
Camstech
Developer of biochemical sensing technologies
Life Sciences TechnologyDaresbury, United Kingdom
LGC - Genomic solutions
Provider of extraction, sequencing and genotyping instruments, reagents and software
Life Sciences TechnologyTeddington, United Kingdom

About Metadeq

What does Metadeq do?

Developer of a blood-based diagnostic test for the detection of NASH and metabolic diseases.

Where is Metadeq headquartered?

Metadeq is headquartered in London, United Kingdom.

When was Metadeq founded?

Metadeq was founded in 2019.

Which sector is Metadeq in?

Metadeq operates in Life Sciences Technology.

Who are Metadeq's competitors?

Companies similar to Metadeq include Yourgene Health, Camstech, and LGC - Genomic solutions.